Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS)

Journal of Substance Abuse Treatment

Volumn 30, Issue 4, 2006, Pages 355-362

  Havard, Alys ^a   Teesson, Maree ^a   Darke, Shane ^a   Ross, Joanne ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Depression; Heroin dependence; Longitudinal; Outcome; Treatment

Indexed keywords

BUPRENORPHINE; METHADONE;

ADULT; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DRUG ABUSE; DRUG DETOXIFICATION; FEMALE; FOLLOW UP; HEROIN DEPENDENCE; HIGH RISK BEHAVIOR; HUMAN; INTERVIEW; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; PREVALENCE; PRIORITY JOURNAL; REHABILITATION CARE; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AUSTRALIA; DEPRESSIVE DISORDER, MAJOR; FEMALE; HEROIN DEPENDENCE; HUMANS; LONGITUDINAL STUDIES; MALE; METHADONE; MIDDLE AGED; QUESTIONNAIRES; RESIDENTIAL TREATMENT; SORPTION DETOXIFICATION; TREATMENT OUTCOME;

EID: 33646563472     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2006.03.012     Document Type: Article

References (56)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. (1994), APA, Washington, DC
2. Andrews G., Hall W., Teesson M., and Henderson S. The mental health of Australians. National Survey of Mental Health and Wellbeing Report 2 (1999), Commonwealth Department of Health and Aged Care, Canberra
3. Anglin M.D., Hser Y., and Grella C.E. Drug addiction and treatment careers among clients in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 11 (1997) 308-323
4. Best D., Gossop M., Man L., Finch R., Greenwood J., and Strang J. Accidental and deliberate overdose among opiate addicts in methadone maintenance treatment: Are deliberate overdoses systematically different?. Drug and Alcohol Review 19 (2000) 213-216
5. Brienza R.S., Stein M.D., Chen M.H., Gogineni A., Sobota M., Maksad J., et al. Depression among needle exchange program and methadone maintenance clients. Journal of Substance Abuse Treatment 18 (2000) 331-337
6. Brooner R.K., King V.L., Kidorf M., Schmidt Jr. C.W., and Bigelow G.E. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry 54 (1997) 71-80
7. Chatham L.R., Knight K., Joe G.W., and Simpson D.D. Suicidality in a sample of methadone maintenance patients. American Journal of Drug and Alcohol Abuse 21 (1995) 345-361
8. Compton W.M., Cottler L.B., Jacobs J.L., Ben-Abdallah A., and Spitznagel E.E. The role of psychiatric disorders in predicting drug dependence treatment outcomes. American Journal of Psychiatry 160 (2003) 890-895
9. Cottler L.B., Compton W.M., Mager D., Spitznagel E.L., and Janca A. Post-traumatic stress disorder among substance abusers from the general population. American Journal of Psychiatry 149 (1992) 664-670
10. Croughan J.L., Miller J.P., Wagelin D., and Whitmen B.W. Psychiatric illness in male and female narcotic addicts. Journal of Clinical Psychiatry 43 (1982) 225-228
11. Darke S., Hall W., Heather N., Wodak A., and Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opioid users: The Opiate Treatment Index. British Journal of Addiction 87 (1992) 593-602
12. Darke S., and Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug and Alcohol Dependence 48 (1997) 135-141
13. Darke S., and Ross J. The relationship between suicide and heroin overdose among methadone maintenance patients in Sydney, Australia. Addiction 96 (2001) 1443-1453
14. Darke S., Ross J., Teesson M., Ali R., Ritter A., and Lynskey M. Factors associated with 12 months continuous heroin abstinence: Findings from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment 28 (2005) 255-263
15. Darke S., Ross J., Teesson M., and Lynskey M. Health service utilisation and benzodiazepine use among heroin users: Findings from the Australian Treatment Outcome Study (ATOS). Addiction 98 (2003) 1129-1135
16. Darke S., Topp L., Kaye S., and Hall W. Heroin use in New South Wales, Australia, 1996-2000: 5 Years monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS). Addiction 97 (2002) 179-186
17. Dean A.J., Bell J., Christie M.J., and Mattick R.P. Depressive symptoms during buprenorphine vs. methadone maintenance: Findings from a randomised, controlled trial in opioid dependence. European Psychiatry 19 (2004) 510-513
18. DeLeon G.A., Skodol A., and Rosentahal M.S. Phoenix House: Changes in psychopathological signs of resident drug addicts. Archives of General Psychiatry 28 (1973) 131-135
19. Dorus W., and Senay E.C. Depression, demographic dimensions, and drug abuse. American Journal of Psychiatry 137 (1980) 699-704
20. Foster T., Gillespie K., McClelland R., and Patterson C. Risk factors for suicide independent of DSM-III-R Axis 1 disorder. British Journal of Psychiatry 175 (1999) 175-179
21. Gossop M., Marsden J., Stewart S., and Rolfe A. Treatment retention and 1 year outcomes for residential programmes in England. Drug and Alcohol Dependence 57 (1999) 89-98
22. Gossop M., Marsden J., Stewart D., and Treacy S. Change and stability of change after treatment of drug misuse. 2 Year outcomes from the National Treatment Outcome Research Study (UK). Addictive Behaviors 27 (2002) 155-166
23. Gowing L., Cooke R., Biven A., and Watts D. Towards better practice in therapeutic communities (2002), Australasian Therapeutic Communities Association, Bangalow
24. Harris E.C., and Barraclough B. Suicide as an outcome for mental disorders. British Journal of Psychiatry 170 (1997) 205-228
25. Hatsukami D., and Pickens R.W. Posttreatment depression in an alcohol and drug abuse population. American Journal of Psychiatry 139 (1982) 1563-1566
26. Hser Y., Grella C.E., Hseih S., Anglin M.D., and Brown B. Prior treatment experience related to process and outcomes in DATOS. Drug and Alcohol Dependence 57 (1999) 137-150
27. Hubbard R.L., Craddock S.G., Flynn P.M., Anderson J., and Etheridge R.M. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behavior 11 (1997) 261-278
28. Keane T.M., and Kaloupek D.G. Comorbid psychiatric disorders in PTSD. Implications for research. Annals of the New York Academy of Sciences 821 (1997) 24-34
29. Kessler R.C., Sonnega A., Bromet E., Hughes M., and Nelson C.B. Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry 53 (1995) 1048-1060
30. Khantzian E.J., and Treece C. DSM-III psychiatric disorders of narcotic addicts. Archives of General Psychiatry 42 (1985) 1067-1071
31. Kjelsberg E., Winther M., and Dahl A.A. Overdose deaths in young substance abusers: Accidents or hidden suicides. Acta Psychiatrica Scandinavica 91 (1995) 236-242
32. Kosten T.R., Morgan C., and Kosten T.A. Depressive symptoms during buprenorphine treatment of opioid abusers. Journal of Substance Abuse Treatment 7 (1990) 51-54
33. Kosten T.R., and Rounsaville B.J. Suicidality among opioid addicts: 2.5 Year follow-up. American Journal of Drug and Alcohol Abuse 14 (1988) 357-369
34. Magruder-Habib K., Hubbard R.L., and Ginzburg H.M. Effects of drug misuse treatment on symptoms of depression and suicide. International Journal of the Addictions 27 (1992) 1035-1065
35. Mattick R.M., and Hall W. Are detoxification programmes effective?. Lancet 347 (1996) 97-100
36. McLellan A.T., Childress A.R., Griffith J., and Woody G.E. The psychiatrically severe drug abuse patient: Methadone maintenance or therapeutic community?. American Journal of Drug and Alcohol Abuse 10 (1984) 77-95
37. McLellan A.T., Luborsky L., Woody G.E., O'Brien C.P., and Kron R. Are the "addiction-related" problems of substance abusers really related?. Journal of Nervous and Mental Disease 169 (1981) 232-239
38. National Drug Strategy. National policy on methadone treatment (1997), Commonwealth Department of Health and Family Services, Canberra
39. Nishimoto R.H., and Gordon L.Y. The course of depressive symptoms over time for women who completed drug treatment. Journal of Substance Abuse Treatment 14 (1997) 123-131
40. Nunes E.V., and Levin F.R. Treatment of depression in patients with alcohol or other drug dependence, a meta-analysis. Journal of American Medical Association 291 (2004) 1887-1896
41. Nunes E.V., Sullivan M.A., and Levin F.R. Treatment of depression in patients with opiate dependence. Biological Psychiatry 56 (2004) 793-802
42. Robins L.N., Helzer J.E., Croughan J., and Ratcliff K.S. National Institute of Mental Health Diagnostic Interview Schedule: Its history, characteristics, and validity. Archives of General Psychiatry 38 (1981) 381-389
43. Ross J., Teesson M., Darke S., Lynskey M., Ali R., Ritter A., et al. The characteristics of heroin users entering treatment: Findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Review 24 (2005) 411-418
44. Rossow I., and Laurintzen G. Balancing on the edge of death: Suicide attempts and life-threatening overdoses among drug addicts. Addiction 94 (1999) 209-219
45. Rounsaville B.J., and Kleber H.D. Untreated opiate addicts: How do they differ from those seeking treatment?. Archives of General Psychiatry 42 (1985) 1072-1077
46. Rounsaville B.J., Weissman M.M., Crits-Christoph K., Wilber C., and Kleber H. Diagnosis and symptoms of depression in opiate addicts: Course and relationship to treatment outcome. Archives of General Psychiatry 39 (1982) 151-156
47. Sanchez-Carbonell J., Cami J., and Brigos B. Follow-up of heroin addicts in Spain (EMETYST Project); Results 1 year after treatment admission. British Journal of Addiction 83 (1988) 1439-1448
48. Simpson D.D. Treatment for drug abuse: Follow-up outcomes and length of time spent. Archives of General Psychiatry 38 (1981) 875-880
49. Simpson D.D. Effectiveness of drug abuse treatment: A review of research from field settings. In: Egertson J., Fox D., and Leshner A. (Eds). Treating drug abusers effectively (1997), Blackwell, Oxford
50. Spitzer R.L., Kroenke K., Linzer M., Hahn S.R., Williams J.B.W., deGruy F.V.I., et al. Health-related quality of life in primary care patients with mental disorders. Journal of the American Medical Association 274 (1995) 1511-1517
51. SPSS. SPSS for Windows, 12.0.1 (2003), SPSS, Chicago
52. Teesson M., Havard A., Fairbairn S., Ross J., Lynskey M., and Darke S. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): Prevalence, correlates and treatment seeking. Drug and Alcohol Dependence 78 (2005) 309-315
53. Ware J.E., Kosinski M., and Keller S.D. A 12-item Short-Form health survey: Construction of scales, and preliminary tests of reliability and validity. Medical Care 34 (1996) 220-233
54. Weissman M.D., Slobetz F., Prusoff B., Mesritz M., and Howard P. Clinical depression among narcotic addicts maintained on methadone in the community. American Journal of Psychiatry 133 (1976) 1434-1438
55. World Health Organization. Composite International Diagnostic Interview (version 1.1) (1993), Author, Geneva
56. Zuckerman M., Sola S., Masterton J.W., and Angelone J.V. MMPI patterns in drug abusers before and after treatment in therapeutic communities. Journal of Consulting and Clinical Psychology 43 (1975) 286-296